Monday , 9 March 2015

Latest News
Yesterday’s Sizzlers Under Review – Regulus Therapeutics, (NASDAQ:RGLS), Microvision, (NASDAQ:MVIS), bluebird bio, (NASDAQ:BLUE), Ur-Energy, (NYSEMKT:URG)

Yesterday’s Sizzlers Under Review - Regulus Therapeutics, (NASDAQ:RGLS), Microvision, (NASDAQ:MVIS), bluebird bio, (NASDAQ:BLUE), Ur-Energy, (NYSEMKT:URG)

Insights about U.S. Stocks that landed in the Green-Zone during Thursday's trade, are depicted underneath: Regulus Therapeutics Inc (NASDAQ:RGLS)'s shares picked up 13.97%, and cl ...

Read More »

Biotech Sector Active Movers - Achillion Pharmaceuticals, (ACHN), Amgen, (AMGN), bluebird bio, (BLUE), ZIOPHARM Oncology, (ZIOP)

U.S. stock ascended on Thursday, after a three-day rally in the Standard & Poor’s 500 Index, as the European Central Bank left standard interest rates unaffected and ECB Presi ...

Read More »

Biotech Fueled Investor Interest - Juno Therapeutics (JUNO), Kite Pharma (KITE), Chimerix (CMRX), bluebird bio (BLUE)

U.S. stocks fell Thursday, as a pair of unsatisfactory bank earnings reports weighed down financial shares. The Dow Jones Industrial Average droop 76 points, or 0.4%, to 17351. Th ...

Read More »

Biotechnology Stocks At A Glance: Agenus (AGEN), Brainstorm Cell Therapeutics (BCLI), bluebird bio (BLUE), CASI Pharmaceuticals (CASI)

The biotechnology sector, the cutting edge of the pharmaceuticals industry, has conveyed incredible profits for investors. The sector has high-profile fans. Jim Mellon, who made a ...

Read More »
scroll to top